ND0612
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for ND0612, covering 2018-11-23 to 2026-07-09. Get the full timeline:
Most recent: Clinical Trial Results: A Safety, Tolerability and Levodopa Pharmacokinetics Study of Repeated ND0612 in Parkinson's Disease Patients [Phase 2]